Previously, we established a system whereby an intergenic region from mouse hepatitis virus (MHV) inserted into an MHV defective interfering (DI) RNA led to transcription of a subgenomic DI RNA in helper virus-infected cells. By using this system, the duration of a primary transcription initiation activity which transcribes subgenomic-size RNAs from the genomic-size RNA template in MHV-infected cells was examined. Efficient DI genomic and subgenomic RNA synthesis was observed when the DI RNA was transfected at 1, 3, 3.5, 5, and 6 h postinfection, indicating that all activities which are necessary for MHV RNA synthesis are present continuously during the first 6 h of infection. The effect of subgenomic DI RNA synthesis on DI genomic RNA replication was then examined. Replication efficiency of the DI genomic RNA which synthesized the subgenomic RNA was approximately 70%o lower than that of DI genomic RNA which did not synthesize the subgenomic DI RNA in MHV-infected cells. Cotransfection of two different-size DI RNAs demonstrated that replication of the larger DI RNA was strongly inhibited by replication of the smaller genomic DI RNA. Cotransfection of two DI RNA species of the same length into MHV-infected cells demonstrated that reduced replication of the genomic DI RNA which synthesizes the subgenomic RNA did not affect the replication of cotransfected DI RNA, demonstrating that the reduction in DI genomic RNA replication works only in cis, not in trans. Therefore, the previously proposed hypothesis that coronavirus subgenomic RNA synthesis may inhibit the replication of genomic RNA by competing for a limited amount of virus-derived factors seems unlikely. Possible mechanisms of coronavirus transcription are discussed.
RNA replication was then examined. Replication efficiency of the DI genomic RNA which synthesized the subgenomic RNA was approximately 70%o lower than that of DI genomic RNA which did not synthesize the subgenomic DI RNA in MHV-infected cells. Cotransfection of two different-size DI RNAs demonstrated that replication of the larger DI RNA was strongly inhibited by replication of the smaller genomic DI RNA. Cotransfection of two DI RNA species of the same length into MHV-infected cells demonstrated that reduced replication of the genomic DI RNA which synthesizes the subgenomic RNA did not affect the replication of cotransfected DI RNA, demonstrating that the reduction in DI genomic RNA replication works only in cis, not in trans. Therefore, the previously proposed hypothesis that coronavirus subgenomic RNA synthesis may inhibit the replication of genomic RNA by competing for a limited amount of virus-derived factors seems unlikely. Possible mechanisms of coronavirus transcription are discussed.
Mouse hepatitis virus (MHV), a coronavirus, is an enveloped virus containing a single-stranded, positive-sense RNA genome of approximately 31 kb (14, 15) . In MHV-infected cells, seven to eight species of virus-specific subgenomic mRNAs comprising a 3'-coterminal nested-set structure (12, 17) are synthesized. These subgenomic mRNAs are named mRNAs 1 to 7, according to decreasing order of size (12, 17) . mRNA 1 is structurally identical to the genomic RNA detected in MHV particles, whereas the other subgenomic mRNAs are not packaged into virions because of the lack of a packaging signal (27, 35) . The 5' end of the MHV genomic RNA contains a 72-to 77-nucleotide-long leader sequence (11, 13, 34) . Downstream of the leader sequence are the MHV-specific genes, each of which is separated by a special short stretch of sequence, the intergenic sequence. A sequence identical to the leader sequence, of 72 to 77 nucleotides, is also found at the 5' end of each MHV mRNA species, though these leader sequences are encoded for only once in the genomic strand. The leader sequences are fused with the mRNA body sequence which starts from the intergenic site consensus sequence of UCUAAAC (24, 33) .
The mechanisms which produce this characteristic coronavirus mRNA structure are particularly intriguing. It has been proposed that coronavirus uses a unique form of leader RNA-primed transcription in which a leader RNA is transcribed from the 3' end of the genomic-size, negative-strand template RNA, dissociates from the template, and then rejoins the template RNA at downstream intergenic regions to serve as the primer for mRNA transcription (10) . There is much experimental data to support this transcription model * Corresponding author.
(1, 2, 10, 25). However, Sethna et al. demonstrated the presence of subgenomic-size, negative-strand RNAs containing the antileader sequence in coronavirus-infected cells (31, 32) . In addition, subgenomic replicative intermediate (RI) RNAs corresponding to each MHV subgenomic mRNA species have been demonstrated in MHV-infected cells (30) . In the leader RNA-primed transcription model, only a genomic-size negative-strand template is proposed to be used for subgenomic mRNAs; the presence of negative-strand subgenomic RNAs and subgenomic RI RNAs cannot be explained by this model. The presence of negative-strand subgenomic RNAs containing antileader sequence leads to the proposal that subgenomic mRNA synthesis may be involved in the replication of each subgenomic RNA species (31, 32) . Furthermore, it was proposed that replicating subgenomic mRNAs may compete with the replicating genome for limiting factors required in RNA replication, possibly the RNA polymerase, in much the same way as do defective interfering (DI) RNAs (32) . It should be noted that definitive evidence for any coronavirus subgenomic RNA amplification model has not yet been obtained.
We have previously established a system that exploits DI RNAs of MHV for deciphering the mechanism of coronavirus mRNA transcription (20) . An MHV DIssF-derived complete cDNA clone containing an inserted intergenic region was constructed (20, 27) . After transfection of the in vitrosynthesized DI RNA into MHV-infected cells, replication of DI genomic RNA as well as transcription of the DI subgenomic RNA were observed (20) . This study clearly demonstrates that the initial subgenomic RNA (20) . The structure of each mutant is depicted in Fig. 1 .
RNA transcription and transfection. Plasmid DNAs were linearized by XbaI digestion and transcribed with T7 RNA polymerase as previously described (21) . The lipofection procedure (7) was used for RNA transfection as previously described (20) . Preparation of virus-specific intracellular RNA and Northern (RNA) blotting. Virus-specific RNAs were extracted from MHV-infected cells as previously described (26) . Intracellular RNA was denatured and electrophoresed through a 1% agarose gel containing formaldehyde and transferred to a nylon membrane as previously described (20) . After G) h p.i. Intracellular RNA was extracted at 9 h p.i., and virusspecific RNA species were separated on 1% formaldehyde gels and transferred to Biodyne nylon filters. MHV-specific RNA species were detected by using probe 2 (see Fig. 1 (8) . Since DIssE RNA requires helper virus infection for its replication, it probably shares enzymatic activities for its replication with APR6-2 (22) . If To examine how efficiently DIssE replication inhibits the replication of APR6-2, the same amounts of in vitro-synthesized DIssE-specific RNA, DE5-w3 DI RNA (21) , and APR6-2 DI RNA were mixed in the lipofection solution and then transfected into MHV-A59-infected cells at 3 h p.i., and the intracellular virus-specific RNA was extracted 7 h p.i. As a control, equal amounts of DE5-w3 RNA and APR6-2 DI RNA were mixed with equal amounts of irrelevant in vitrosynthesized RNA species and individually transfected into MHV-infected cells. Levels of DI genomic RNA replication were estimated by Northern blot analysis using probe 1, which specifically hybridizes to DI genomic RNA and MHV genomic RNA (Fig. 4) . Efficient replication of DE5-w3 DI RNA was observed in the DE5-w3 DI RNA-transfected cells, and the amount of the accumulated DE5-w3 DI RNA was approximately 40 times higher than that of APR6-2 DI RNA (Fig. 4, lanes D and F) (Fig. 1 ).
To examine whether the effect of reduced replication works in trans, equal amounts of in vitro-synthesized NDI, PR6M, and PR6-5M were prepared. Mixtures of PR6M and NDI and of PR6-5M and NDI were transfected into MHV-A59-infected cells at 3 h p.i. At 7 h p.i., intracellular RNA was extracted and equal amounts of RNA were applied to agarose gels. The amount of DI RNA replication was then examined by Northern blot analysis. Efficient replication of PR6M and PR6-5M was detected in MHV-A59-infected cells by using probe 3, the NdeI-NsiI fragment of PR6 MHV DI cDNA that specifically binds to MHV genomic RNA and to PR6M and PR6-5M genomic DI RNA but not to NDI genomic DI RNA. Accumulation of PR6M genomic RNA, which synthesizes subgenomic DI RNA, was about 80% lower than that of PR6-5M in NDI-cotransfected cells (Fig.  Sb, lanes I and J) . This observation was consistent with the observation described above. In contrast to this finding, there was no detectable difference between the accumulation of NDI in PR6M replicating cells and in PR6-5M replicating cells when the AccI-AccI fragment of MHV cDNA was used as a probe (probe 4; Fig. 1) (Fig. Sa, lanes H and I) . The same conclusion, based on three independent experiments, was that the limited reduction in replication resulting from subgenomic DI RNA synthesis worked in the cis but not in the trans configuration. 
DISCUSSION
Primary transcription initiation activity existed continuously during at least the first 6 h of MHV RNA synthesis. In this study, it was unambiguously demonstrated that MHV RNA synthesis activities, including primary transcription and secondary transcription, were continuously present from 1 to at least 6 h p.i. These results strongly indicate that positive-or negative-sense genomic RNA synthesized later in infection not only is used for subsequent RNA replication but also serves as a template for the initiation of primary transcription. The results obtained from this study were not consistent with the observation reported by Brayton et al. (3, 4) that an activity producing the negative-strand genomic RNA is present only early in infection but are consistent with the observation made by Sawicki and Sawicki (29) in which the rate of overall negative-strand RNA synthesis increases until 5 to 6 h p.i. in MHV-infected cells. Probably this genomic-size negative-strand RNA continuously synthesized from 1 to 6 h p.i. is biologically functional.
Mechanism of coronavirus subgenomic RNA synthesis. From the discovery of the subgenomic negative-strand RNA species, it was proposed that coronavirus mRNA undergoes an amplification process which might inhibit the replication of genomic RNA by competing for a limited amount of virus-derived factors, including RNA polymerases (32 (Fig. 4) (20) (Fig. 4) (32) .
From the data obtained in this study and those obtained previously by us and others, the following different coronavirus transcription models are considered.
In the first of these models, coronavirus subgenomic RNA secondary transcription may undergo its amplification step at a reduced efficiency while sharing the same activities which are used for genomic RNA replication. Our data indicated that the accumulation of subgenomic DI RNA was much less efficient than that of DIssE RNA. Therefore, if subgenomic RNAs are amplified via a mechanism which shares RNA replication machinery, it is amplified, unexpectedly, at a reduced efficiency. This reduced efficiency would suggest a lack of competition with genomic RNA replication. Perhaps the low efficiency of subgenomic DI RNA amplification is due to the structure at its positive-sense 5' region; it contains the complete leader sequence at the 5' end but lacks a region downstream of the leader sequence which is present on the genomic RNA. In this model, the limited reduction in the genomic DI RNA accumulation cannot be due to competition for helper virus-derived factors; it must be due to another, yet unknown mechanism, because the effect of reduced replication worked in cis but not in trans. One possible explanation is that during the time that a certain percentage of DI genomic-size RNAs are functioning as templates for primary transcription, they cannot be used for genomic RNA replication, at least temporarily.
In a second model, it is possible that secondary transcription undergoes the amplification step via a transcriptional activity which differs from genomic RNA replication activity; thus, competition of virus-derived factors would not be a factor. This mechanism, again, would account for the lower efficiency of subgenomic RNA amplification relative to replicative functions, and the limited reduction in DI genomic RNA accumulation seen in those DIs synthesizing subgenomic RNA may be explained as discussed above.
If secondary transcription involves an amplification step and if the efficiencies of degradation of each subgenomic mRNA species are the same, then it is reasonable to hypothesize that the molar ratio of each subgenomic RNA may vary during the course of infection, because smaller subgenomic RNAs should accumulate more efficiently than larger mRNA species. Furthermore, larger mRNAs would be expected to degrade more efficiently than smaller ones. If this is the case, an even more efficient accumulation of smaller subgenomic RNA species would be expected. However, it was demonstrated that the ratio of the amount of each subgenomic RNA is essentially constant during MHV replication (17) . If primary transcription is short-lived, then it is quite reasonable to speculate that the subgenomic RNA accumulates by an amplification mechanism. However, as is demonstrated in this study, primary transcription takes place continuously during the first 6 h of MHV RNA synthesis. Considering these points, we propose a third model for coronavirus transcription (Fig. 6 ).
This new model proposes that secondary transcription is not an amplification step but is involved only in the synthesis of negative-strand subgenomic RNA from the subgenomic positive-strand RNA which was synthesized during primary transcription. The synthesized negative-strand subgenomic RNA does not undergo further amplification but results, in this model, in dead-end products. Only a negative-strand RNA elongates on the subgenomic RI RNA. Because the 3'-end regions of the positive-strand subgenomic mRNAs and the positive-strand genomic RNA are identical structures, it is reasonable to hypothesize that the negative-strand subgenomic RNA is copied from the positive-strand subgenomic mRNA with almost the same efficiency as genomicsize negative-strand RNA synthesis. Because of the lack of other essential sequences at the 5' region of the positivestrand subgenomic RNA, positive-strand subgenomic RNA is not synthesized from the negative-strand subgenomic RNAs. This model is consistent with most previously described observations; subgenomic DI RNA synthesis does not occur in subgenomic DI RNA-transfected, MHV-infected cells (20) , subgenomic RI RNAs are present in MHVinfected cells (30) , the molar ratio of each subgenomic replicative-form (RF) RNA is parallel to that of subgenomic J. VIROL. (30) , and antileader sequences are present on negative-strand subgenomic RNA (31) . This model also agrees with our observation that primary transcription is continuous during at least the first 6 h of MHV RNA synthesis. This finding suggests that continuously synthesized positive-strand subgenomic RNA made by a primary transcription mechanism is continuously available as a template for the negative-strand subgenomic RNA species. Furthermore, we have recently observed that the negativestrand subgenomic DI RNA was indeed synthesized after transfection of in vitro-synthesized positive-strand subgenomic DI RNA into MHV-infected cells (9) . This observation strongly supports this model. Sawicki and Sawicki (30) proposed a different model to explain coronavirus transcription. In their model, the subgenomic negative-strand RNAs are initially synthesized from the input genomic RNA (primary transcription). Then, the positive-strand subgenomic RNA is synthesized on the subgenomic-sized negative-stranded RNA (secondary transcription) (30) . This model is also consistent with the bulk of observations except that the genome-length RI RNA does not produce the subgenomic-size RF RNAs after RNase digestion (30) . If Sawicki and Sawicki's model is correct, then why are subgenomic-size RF RNAs not produced after RNase treatment of the genomic-size RI RNA that is elongating subgenomic negative-strand RNA species on the genomic-size positive-sense RNA? From this study and our previous study, it is evident that the subgenomic RNA must be initially synthesized from the genomic-size RNA (20) and that this primary transcription continues from 1 to at least 6 h p.i. Therefore, any transcription model should propose that subgenomic RF RNAs be generated after RNase digestion of the genomic-size RI RNA. At present, it is not clear why subgenomic RF RNAs are not produced from genomelength RI RNA.
In these studies using the MHV DI cDNA system, it was unambiguously demonstrated that coronavirus transcription is at least a two-step process involving primary transcription and secondary transcription. As discussed above, a number of different models of MHV transcription can be considered. This study and studies now in progress to unravel the mechanism of subgenomic RNA synthesis through the investigation of MHV DI cDNA clones should prove to be the key to understanding the coronavirus transcription mechanism.
